Advances in MALDI mass spectrometry in clinical diagnostic applications

Topics in Current Chemistry

Volumn 336, Issue , 2014, Pages 139-176

  Ng, Eddy W Y ^a   Wong, Melody Y M ^a   Poon, Terence C W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biomarkers; Clinical diagnostics; Matrix assisted laser desorption ionization (MALDI); Surface assisted laser desorption ionization (SALDI); Surface enhanced laser desorption ionization (SELDI); Time of flight (TOF)

Indexed keywords

BIOLOGICAL MARKER;

DIAGNOSTIC PROCEDURE; GLYCOSYLATION; HIGH THROUGHPUT SCREENING; HUMAN; MASS SPECTROMETRY; METHODOLOGY; PROTEOMICS; REVIEW;

BIOLOGICAL MARKERS; CLINICAL LABORATORY TECHNIQUES; GLYCOSYLATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84890918909     PISSN: 03401022     EISSN: None     Source Type: Book Series    
DOI: 10.1007/128-2012-413     Document Type: Review

References (161)

1. Karas M, Bachmann D, Hillenkamp F (1985) Influence of the wavelength in high-irradiance ultraviolet laser desorption mass spectrometry of organic molecules. Anal Chem 57: 2935-2939
2. Tanaka K, Waki H, Ido Y, Akita S, Yoshida Y, Yoshida T (1988) Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2:151-153
3. Zenobi R, Knochenmuss R (1998) Ion formation in MALDI mass spectrometry. Mass Spectrom Rev 17:337-366
4. Pang RTK, Johnson PJ, Chan CML, Kong EKC, Chan ATC, Sung JJY, Poon TCW (2004) Technical evaluation ofMALDI-TOF mass spectrometry for quantitative proteomic profiling - matrix formulation and application. Clin Proteomics 1:259-270
5. Kam RKT, Poon TCW, Chan HLY, Wong N, Hui AY, Sung JJY (2007) High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis. Clin Chem 53:1254-1263
6. Roskey MT, Juhasz P, Smirnov IP, Takach EJ, Martin SA, Haff LA (1996) DNA sequencing by delayed extraction-matrix-assisted laser desorption/ionization time of flight mass spectrometry. Proc Natl Acad Sci USA 93:4724-4729
7. Guilhaus M (1995) Principles and instrumentation in time-of-flight mass spectrometry. J Mass Spectrom 30:1519-1532
8. Medzihradszky KF, Campbell JM, Baldwin MA, Falick AM, Juhasz P, Vestal ML, Burlingame AL (2000) The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal Chem 72:552-558
9. Suckau D, Resemann A, Schuerenberg M, Hufnagel P, Franzen J, Holle A (2003) A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics. Anal Bioanal Chem 376: 952-965
10. Ho CS, Lam CW, Chan MH, Cheung RC, Law LK, Lit LC, Ng KF, SuenMW, Tai HL (2003) Electrospray ionisation mass spectrometry: Principles and clinical applications. Clin Biochem Rev 24:3-12
11. Thiede B, Hohenwarter W, Krah A, Mattow J, Schmid M, Schmidt F, Jungblut PR (2005) Peptide mass fingerprinting. Methods 35:237-247
12. Kapp E, Schutz F (2007) Overview of tandem mass spectrometry (MS/MS) database search algorithms. Curr Protoc Protein Sci (Chapter 25:Unit25.2
13. Krutchinsky AN, Chait BT (2002) On the nature of the chemical noise in MALDI mass spectra. J Am Soc Mass Spectrom 13:129-134
14. van Kampen JJ, Burgers PC, de Groot R, Gruters RA, Luider TM (2011) Biomedical application of MALDI mass spectrometry for small-molecule analysis. Mass Spectrom Rev 30:101-120
15. Alterman MA, Gogichayeva NV, Kornilayev BA (2004) Matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry-based amino acid analysis. Anal Biochem 335: 184-191
16. Fuchs B, Suss R, Schiller J (2010) An update of MALDI-TOF mass spectrometry in lipid research. Prog Lipid Res 49:450-475
17. Goetz JA, Novotny MV, Mechref Y (2009) Enzymatic/chemical release of O-glycans allowing MS analysis at high sensitivity. Anal Chem 81:9546-9552
18. Galesio M, Nunez C, Diniz MS, Welter R, Lodeiro C, Luis Capelo J (2012) Matrix-assisted laser desorption/ionization time of flight spectrometry for the fast screening of oxosteroids using aromatic hydrated hydrazines as versatile probe. Talanta 100:262-269
19. Cheng AJ, Chen LC, Chien KY, Chen YJ, Chang JT, Wang HM, Liao CT, Chen IH (2005) Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51:2236-2244
20. Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR (2008) Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope 118:61-68
21. Pakharukova NA, Pastushkova LK, Trifonova OP, Pyatnitsky MA, Vlasova MA, Nikitin IP, Moshkovsky SA, Nikolayev EN, Larina IM (2009) Optimization of serum proteome profiling of healthy humans. Hum Physiol 35:350-356
22. Sui W, Dai Y, Zhang Y, Chen J, Liu H, Huang H (2012) Proteomic profiling of nephrotic syndrome in serum using magnetic bead based sample fractionation & MALDI-TOF MS. Indian J Med Res 135:305-311
23. Jimenez CR, El Filali Z, Knol JC, Hoekman K, Kruyt FA, Giaccone G, Smit AB, Li KW (2007) Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS. Proteomics Clin Appl 1:598-604
24. Wong MYM, Yu KOY, Poon TCW, Ang IL, Law MK, Chan KYW, Ng EWY, Ngai SM, Sung JJY, Chan HLY (2010) A magnetic bead-based serum proteomic fingerprinting method for parallel analytical analysis and micropreparative purification. Electrophoresis 31: 1721-1730
25. Ng PC, Ang IL, Chiu RW, Li K, Lam HS, Wong RP, Chui KM, Cheung HM, Ng EW, Fok TF, Sung JJ, Lo YM, Poon TC (2010) Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 120:2989-3000
26. Villanueva J, Martorella AJ, Lawlor K, Philip J, Fleisher M, Robbins RJ, Tempst P (2006) Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol Cell Proteomics 5:1840-1852
27. Villanueva J, Nazarian A, Lawlor K, Yi SS, Robbins RJ, Tempst P (2008) A sequencespecific exopeptidase activity test (SSEAT) for "functional" biomarker discovery. Mol Cell Proteomics 7:509-518
28. Cole LA (1997) Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem 43:2233-2243
29. Lund H, Torsetnes SB, Paus E, Nustad K, Reubsaet L, Halvorsen TG (2009) Exploring the complementary selectivity of immunocapture and MS detection for the differentiation between hCG isoforms in clinically relevant samples. J Proteome Res 8:5241-5252
30. Shiea J, Cho YT, Lin YH, Chang CW, Lo LH, Lee YC, Ke HL, Wu WJ, Wu DC (2008) Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to rapidly screen for albuminuria. Rapid Commun Mass Spectrom 22:3754-3760
31. Cho YT, Chen YS, Hu JL, Shiea J, Yeh SM, Chen HC, Lee YC, Wu DC (2012) The study of interferences for diagnosing albuminuria by matrix-assisted laser desorption ionization/timeof- flight mass spectrometry. Clin Chim Acta 413:875-882
32. Biroccio A, Urbani A, Massoud R, di Ilio C, Sacchetta P, Bernardini S, Cortese C, Federici G (2005) A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Anal Biochem 336:279-288
33. Gelfanova V, Higgs RE, Dean RA, Holtzman DM, Farlow MR, Siemers ER, Boodhoo A, Qian YW, He X, Jin Z, Fisher DL, Cox KL, Hale JE (2007) Quantitative analysis of amyloidbeta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry. Brief Funct Genomic Proteomic 6:149-158
34. Mason DR, Reid JD, Camenzind AG, Holmes DT, Borchers CH (2012) Duplexed iMALDI for the detection of angiotensin I and angiotensin II. Methods 56:213-222
35. Jiang J, Parker CE, Hoadley KA, Perou CM, Boysen G, Borchers CH (2007) Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis. Proteomics Clin Appl 1:1651-1659
36. Anderson NL, Razavi M, Pearson TW, Kruppa G, Paape R, Suckau D (2012) Precision of heavy-light peptide ratios measured by MALDI-Tof mass spectrometry. J Proteome Res 11: 1868-1878
37. Su KY, Chen HY, Li KC, Kuo ML, Yang JC, Chan WK, Ho BC, Chang GC, Shih JY, Yu SL, Yang PC (2012) Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-smallcell lung cancer. J Clin Oncol 30:433-440
38. Stibler H, Jaeken J (1990) Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch Dis Child 65:107-111
39. Stibler H (1991) Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37:2029-2037
40. Barratt J, Smith AC, Feehally J (2007) The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton) 12:275-284
41. Poon TC, Chiu CH, Lai PB, Mok TS, Zee B, Chan AT, Sung JJ, Johnson PJ (2005) Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma. World J Gastroenterol 11:6701-6706
42. Grunewald S, Matthijs G, Jaeken J (2002) Congenital disorders of glycosylation: A review. Pediatr Res 52:618-624
43. Stibler H, Allgulander C, Borg S, Kjellin KG (1978) Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand 204:49-56
44. Ekuni A,Miyoshi E, Ko JH, NodaK, Kitada T, Ihara S, Endo T, Hino A, Honke K, Taniguchi N (2002)Aglycomic approach to hepatic tumors in N-acetylglucosaminyltransferase III (GnT-III) transgenic mice induced by diethylnitrosamine (DEN): Identification of haptoglobin as a target molecule of GnT-III. Free Radic Res 36:827-833
45. Li D, Mallory T, Satomura S (2001) AFP-L3: A new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta 313:15-19
46. Poon TC, Mok TS, Chan AT, Chan CM, Leong V, Tsui SH, Leung TW, Wong HT, Ho SK, Johnson PJ (2002) Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein. Clin Chem 48:1021-1027
47. Noda K, Miyoshi E, Uozumi N, Yanagidani S, Ikeda Y, Gao C, Suzuki K, Yoshihara H, Yoshikawa K, Kawano K, Hayashi N, Hori M, Taniguchi N (1998) Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of alpha-fetoprotein. Hepatology 28:944-952
48. Wada Y, Azadi P, Costello CE, Dell A, Dwek RA, Geyer H, Geyer R, Kakehi K, Karlsson NG, Kato K, Kawasaki N, Khoo KH, Kim S, Kondo A, Lattova E, Mechref Y, Miyoshi E, Nakamura K, Narimatsu H, Novotny MV, Packer NH, Perreault H, Peter- Katalinic J, Pohlentz G, Reinhold VN, Rudd PM, Suzuki A, Taniguchi N (2007) Comparison of the methods for profiling glycoprotein glycans-HUPO human disease glycomics/proteome initiative multi-institutional study. Glycobiology 17:411-422
49. Wada Y, Gu J, Okamoto N, Inui K (1994) Diagnosis of carbohydrate- deficient glycoprotein syndrome by matrix-assisted laser desorption time-of-flight mass spectrometry. Biol Mass Spectrom 23:108-109
50. Wada Y (2006) Mass spectrometry for congenital disorders of glycosylation, CDG. J Chromatogr B Analyt Technol Biomed Life Sci 838:3-8
51. An HJ, Miyamoto S, Lancaster KS, Kirmiz C, Li B, Lam KS, Leiserowitz GS, Lebrilla CB (2006) Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res 5:1626-1635
52. Kirmiz C, Li B, An HJ, Clowers BH, Chew HK, Lam KS, Ferrige A, Alecio R, Borowsky AD, Sulaimon S, Lebrilla CB, Miyamoto S (2007) A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics 6:43-55
53. Kyselova Z, Mechref Y, Al Bataineh MM, Dobrolecki LE, Hickey RJ, Vinson J, Sweeney CJ, Novotny MV (2007) Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res 6:1822-1832
54. Goldman R, Ressom HW, Varghese RS, Goldman L, Bascug G, Loffredo CA, Abdel-Hamid M, Gouda I, Ezzat S, Kyselova Z, Mechref Y, Novotny MV (2009) Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res 15:1808-1813
55. Kyselova Z, Mechref Y, Kang P, Goetz JA, Dobrolecki LE, Sledge GW, Schnaper L, Hickey RJ, Malkas LH, Novotny MV (2008) Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem 54:1166-1175
56. Mechref Y, Hussein A, Bekesova S, Pungpapong V, Zhang M, Dobrolecki LE, Hickey RJ, Hammoud ZT, Novotny MV (2009) Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res 8:2656-2666
57. AlleyWRJr, Vasseur JA, Goetz JA, Svoboda M, Mann BF, Matei DE, Menning N, Hussein A, Mechref Y, Novotny MV (2012) N-Linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res 11:2282-2300
58. Matsumoto K, Shimizu C, Arao T, Andoh M, Katsumata N, Kohno T, Yonemori K, Koizumi F, Yokote H, Aogi K, Tamura K, Nishio K, Fujiwara Y (2009) Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS. J Proteome Res 8:457-462
59. Nordhoff E, Ingendoh A, Cramer R, Overberg A, Stahl B, Karas M, Hillenkamp F, Crain PF (1992) Matrix-assisted laser desorption/ionization mass spectrometry of nucleic acids with wavelengths in the ultraviolet and infrared. Rapid Commun Mass Spectrom 6:771-776
60. Fu DJ, Broude NE, Koster H, Smith CL, Cantor CR (1996) Efficient preparation of short DNA sequence ladders potentially suitable for MALDI-TOF DNA sequencing. Genet Anal 12:137-142
61. Braun A, Little DP, Koster H (1997) Detecting CFTR gene mutations by using primer oligo base extension and mass spectrometry. Clin Chem 43:1151-1158
62. Ross P, Hall L, Smirnov I, Haff L (1998) High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 16:1347-1351
63. Luan J, Yuan J, Li X, Jin S, Yu L, Liao M, Zhang H, Xu C, He Q, Wen B, Zhong X, Chen X, Chan HL, Sung JJ, Zhou B, Ding C (2009) Multiplex detection of 60 hepatitis B virus variants by MALDI-TOF mass spectrometry. Clin Chem 55:1503-1509
64. Liao HK, Su YN, Kao HY, Hung CC, Wang HT, Chen YJ (2005) Parallel minisequencing followed by multiplex matrix-assisted laser desorption/ionization mass spectrometry assay for beta-thalassemia mutations. J Hum Genet 50:139-150
65. Farkas DH, Miltgen NE, Stoerker J, van den Boom D, Highsmith WE, Cagasan L, McCullough R, Mueller R, Tang L, Tynan J, Tate C, Bombard A (2010) The suitability of matrix assisted laser desorption/ionization time of flight mass spectrometry in a laboratory developed test using cystic fibrosis carrier screening as a model. J Mol Diagn 2:611-619
66. Ding C, Lo YM (2006) MALDI-TOF mass spectrometry for quantitative, specific, and sensitive analysis of DNA and RNA. Ann N Y Acad Sci 1075:282-287
67. Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, Ding C (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13:218-223
68. Hidaka H, Hanyu N, Sugano M, Kawasaki K, Yamauchi K, Katsuyama T (2007) Analysis of human serum lipoprotein lipid composition using MALDI-TOF mass spectrometry. Ann Clin Lab Sci 37:213-221
69. Miura D, Fujimura Y, Tachibana H, Wariishi H (2010) Highly sensitive matrix-assisted laser desorption ionization-mass spectrometry for high-throughput metabolic profiling. Anal Chem 82:498-504
70. Vermillion-Salsbury RL, Hercules DM (2002) 9-Aminoacridine as a matrix for negative mode matrix-assisted laser desorption/ionization. Rapid Commun Mass Spectrom 16: 1575-1581
71. Shroff R, Muck A, Svatos A (2007) Analysis of low molecular weight acids by negative mode matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 21:3295-3300
72. Mims D, Hercules D (2004) Quantification of bile acids directly from plasma by MALDITOF- MS. Anal Bioanal Chem 378:1322-1326
73. Law KP, Larkin JR (2011) Recent advances in SALDI-MS techniques and their chemical and bioanalytical applications. Anal Bioanal Chem 399:2597-2622
74. Sunner J, Dratz E, Chen YC (1995) Graphite surface-assisted laser desorption/ionization time-of-flight mass spectrometry of peptides and proteins from liquid solutions. Anal Chem 67:4335-4342
75. Go EP, Prenni JE, Wei J, Jones A, Hall SC, Witkowska HE, Shen Z, Siuzdak G (2003) Desorption/ionization on silicon time-of-flight/time-of-flight mass spectrometry. Anal Chem 75:2504-2506
76. Ren SF, Zhang L, Cheng ZH, Guo YL (2005) Immobilized carbon nanotubes as matrix for MALDI-TOF-MS analysis: Applications to neutral small carbohydrates. J Am Soc Mass Spectrom 16:333-339
77. Zhang J, Wong HY, Guo YL (2005) Amino acids analysis by MALDI mass spectrometry using carbon nanotube as matrix. Chin J Chem 23:185-189
78. Dong X, Cheng J, Li J, Wang Y (2010) Graphene as a novel matrix for the analysis of small molecules by MALDI-TOF MS. Anal Chem 82:6208-6214
79. Zhou X, Wei Y, He Q, Boey F, Zhang Q, Zhang H (2010) Reduced graphene oxide films used as matrix of MALDI-TOF-MS for detection of octachlorodibenzo-p- dioxin. Chem Commun (Camb) 46:6974-6976
80. Soltzberg LJ, Patel P (2004) Small molecule matrix-assisted laser desorption/ionization timeof- flight mass spectrometry using a polymer matrix. Rapid Commun Mass Spectrom 18: 1455-1458
81. Su CL, Tseng WL (2007) Gold nanoparticles as assisted matrix for determining neutral small carbohydrates through laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 79:1626-1633
82. Sanguinet L, Alévêque O, Blanchard P, Dias M, Levillain E, Rondeau D (2006) Desorption/ ionization on self-assembled monolayer surfaces (DIAMS). J Mass Spectrom 41:830-833
83. Lu M, Lai Y, Chen G, Cai Z (2011) Laser desorption/ionization on the layer of graphene nanoparticles coupled with mass spectrometry for characterization of polymers. Chem Commun (Camb) 47:12807-12809
84. Metz TO, Zhang Q, Page JS, Shen Y, Callister SJ, Jacobs JM, Smith RD (2007) The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomark Med 1:159-185
85. Edwards JL, Kennedy RT (2005) Metabolomic analysis of eukaryotic tissue and prokaryotes using negative mode MALDI time-of-flight mass spectrometry. Anal Chem 77:2201-2209
86. Vaidyanathan S, Goodacre R (2007) Quantitative detection of metabolites using matrixassisted laser desorption/ionization mass spectrometry with 9-aminoacridine as the matrix. Rapid Commun Mass Spectrom 21:2072-2078
87. Gogichaeva NV, Alterman MA (2012) Amino acid analysis by means of MALDI TOF mass spectrometry or MALDI TOF/TOF tandem mass spectrometry. Methods Mol Biol 828: 121-135
88. Ng EW, Lam HS, Ng PC, Poon TC (2012) Quantification of citrulline by parallel fragmentation monitoring - A novel method using graphitized carbon nanoparticles and MALDI-TOF/ TOF mass spectrometry. Clin Chim Acta. doi:10.1016/j.cca.2012.10.039
89. Lowenthal MS, Yen J, Bunk DM, Phinney KW (2010) Certification of NIST standard reference material 2389a, amino acids in 0.1 mol/L HCl-quantification by ID LC-MS/MS. Anal Bioanal Chem 397:511-519
90. Shin S, Fung SM, Mohan S, Fung HL (2011) Simultaneous bioanalysis of L-arginine, L-citrulline, and dimethylarginines by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 879:467-474
91. Gobey J, Cole M, Janiszewski J, Covey T, Chau T, Kovarik P, Corr J (2005) Characterization and performance of MALDI on a triple quadrupole mass spectrometer for analysis and quantification of small molecules. Anal Chem 77:5643-5654
92. Volmer DA, Sleno L, Bateman K, Sturino C, Oballa R, Mauriala T, Corr J (2007) Comparison of MALDI to ESI on a triple quadrupole platform for pharmacokinetic analyses. Anal Chem 79:9000-9006
93. Meesters RJ, van Kampen JJ, Scheuer RD, van der Ende ME, Gruters RA, Luider TM (2011) Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry. J Mass Spectrom 46:282-289
94. vanKampen JJ, ReedijkML, Burgers PC, Dekker LJ,HartwigNG, van der Ende IE, de Groot R, Osterhaus AD, Burger DM, Luider TM, Gruters RA (2010) Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: A clinical application ofMALDI mass spectrometry. PLoS One 5:e11409
95. Lesur A, Varesio E, Domon B, Hopfgartner G (2012) Peptides quantification by liquid chromatography with matrix-assisted laser desorption/ionization and selected reaction monitoring detection. J Proteome Res 11:4972-4982
96. Hutchens TW, Yip TT (1993) New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 7:576-580
97. Poon TCW (2007) Opportunities and limitations of SELDI-TOF mass spectrometry in biomedical research - practical advices. Expert Rev Proteomics 4:51-65
98. Li J, Orlandi R, White CN, Rosenzweig J, Zhao J, Seregni E, Morelli D, Yu Y, Meng XY, Zhang Z, Davidson NE, Fung ET, Chan DW (2005) Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin Chem 51:2229-2235
99. Pang RT, Poon TC, Chan KC, Lee NL, Chiu RW, Tong YK, Wong RM, Chim SS, Ngai SM, Sung JJ, Lo YM (2006) Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome. Clin Chem 52:421-429
100. Poon TC, Pang RT, Chan KC, Lee NL, Chiu RW, Tong YK, Chim SS, Ngai SM, Sung JJ, Lo YM (2012) Proteomic analysis reveals platelet factor 4 and beta-thromboglobulin as prognostic markers in severe acute respiratory syndrome. Electrophoresis 33:1894-1900
101. Roelofsen H, Alvarez-Llamas G, Schepers M, Landman K, Vonk RJ (2007) Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry. Proteome Sci 5:2
102. Tang LA, Wang J, Loh KP (2010) Graphene-based SELDI probe with ultrahigh extraction and sensitivity for DNA oligomer. J Am Chem Soc 132:10976-10977
103. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48: 1296-1304
104. Ebert MP, Meuer J, Wiemer JC, Schulz HU, Reymond MA, Traugott U, Malfertheiner P, Rocken C (2004) Identification of gastric cancer patients by serum protein profiling. J Proteome Res 3:1261-1266
105. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z, Zhu L (2005) Evaluation of serum protein profiling by surfaceenhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 51:102-112
106. Poon TCW, Yip TT, Chan ATC, Yip C, Yip V, Mok TSK, Leung TWT, Ho S, Johnson PJ (2003) Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 49:752-760
107. Forde CE, Gonzales AD, Smessaert JM, Murphy GA, Shields SJ, Fitch JP, McCutchen- Maloney SL (2002) A rapid method to capture and screen for transcription factors by SELDI mass spectrometry. Biochem Biophys Res Commun 290:1328-1335
108. Bane TK, LeBlanc JF, Lee TD, Riggs AD (2002) DNA affinity capture and protein profiling by SELDITOF mass spectrometry: Effect of DNA methylation. Nucleic Acids Res 30:e69
109. Lehmann R, Melle C, Escher N, von Eggeling F (2005) Detection and identification of protein interactions of S100 proteins by ProteinChip technology. J Proteome Res 4: 1717-1721
110. Favre-Kontula L, Sattonnet-Roche P, Magnenat E, Proudfoot AE, Boschert U, Xenarios I, Vilbois F, Antonsson B (2008) Detection and identification of plasma proteins that bind GlialCAM using ProteinChip arrays, SELDITOF MS, and nanoLC MS/MS. Proteomics 8:378-388
111. Davies H, Lomas L, Austen B (1999) Profiling of amyloid beta peptide variants using SELDI protein chip arrays. Biotechniques 27:1258-1261
112. Tolson J, Bogumil R, Brunst E, Beck H, Elsner R, Humeny A, Kratzin H, Deeg M, Kuczyk M, Mueller GA, Mueller CA, Flad T (2004) Serum protein profiling by SELDI mass spectrometry: Detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest 84:845-856
113. Schweigert FJ, Wirth K, Raila J (2004) Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay. Proteome Sci 2:5
114. Eriksson J, Woschnagg C, Fernvik E, Venge P (2007) A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein. J Leukoc Biol82:1491-1500
115. Poon TC, Chan KC, Ng PC, Chiu RW, Ang IL, Tong YK, Ng EK, Cheng FW, Li AM, Hon EK, Fok TF, Lo YM (2004) Serial analysis of plasma proteomic signatures in pediatric patients with severe acute respiratory syndrome and correlation with viral load. Clin Chem 50:1452-1455
116. Woodbury RL, McCarthy DL, Bulman AL (2012) Profiling of urine using ProteinChip® technology. Methods Mol Biol 818:97-107
117. Grus FH, Podust VN, Bruns K, Lackner K, Fu S, Dalmasso EA, Wirthlin A, Pfeiffer N (2005) SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci 46:863-876
118. Tomosugi N, Kitagawa K, Takahashi N, Sugai S, Ishikawa I (2005) Diagnostic potential of tear proteomic patterns in Sjo?gren's syndrome. J Proteome Res 4:820-825
119. Hida RY, Ohashi Y, Takano Y, Dogru M, Goto E, Fujishima H, Saito I, Saito K, Fukase Y, Tsubota K (2005) Elevated levels of human alpha-defensin in tears of patients with allergic conjunctival disease complicated by corneal lesions: Detection by SELDI ProteinChip system and quantification. Curr Eye Res 30:723-730
120. Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH Jr, Bowser R (2005) Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 95: 1461-1471
121. Simonsen AH, McGuire J, Podust VN, Davies H, Minthon L, Skoog I, Andreasen N, Wallin A, Waldemar G, Blennow K (2008) Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease. Neurobiol Aging 29:961-968
122. Siegmund R, Kiehntopf M, Deufel T (2009) Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS. Clin Biochem 2: 1136-1143
123. Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, Sfakianaki AK, Pettker CM, Magloire L, Funai E, Norwitz ER, Paidas M, Copel JA, Weiner CP, Lockwood CJ, Buhimschi IA (2007) Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 4:e18
124. Park JS, Oh KJ, Norwitz ER, Han JS, Choi HJ, Seong HS, Kang YD, Park CW, Kim BJ, Jun JK, Syn HC (2008) Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry. Reprod Sci 15:457-468
125. Ma Z, Liu C, Deng B, Dong S, Tao G, Zhan X, Wang C, Liu S, Qu X (2010) Different protein profile in amniotic fluid with nervous system malformations by surface-enhanced laser desorption- ionization/time-of-flight mass spectrometry (SELDI-TOF-MS) technology. J Obstet Gynaecol Res 36:1195-1203
126. Luciano-Montalvo C, Ciborowski P, Duan F, Gendelman HE, Meléndez LM (2008) Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages. Placenta 29:1016-1023
127. Wibom C, Morén L, Aarhus M, Knappskog PM, Lund-Johansen M, Antti H, Bergenheim AT (2009) Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype. J Neurooncol 94:321-331
128. Cadron I, Van Gorp T, Moerman P, Waelkens E, Vergote I (2011) Proteomic analysis of laser microdissected ovarian cancer tissue with SELDI-TOF MS. Methods Mol Biol 755:155-163
129. Poon TC, Sung JJ, Chow SM, Ng EK, Yu AC, Chu ES, Hui AM, LeungWK(2006) Diagnosis of gastric cancer by serum proteomic fingerprinting. Gastroenterology 130:1858-1864
130. Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, Sung JJ (2005) Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: A pilot study. Clin Chem 51:328-335
131. Liu W, Li X, Ding F, Li Y (2008) Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis. Scand J Rheumatol 37:94-102
132. Fung ET, Yip TT, Lomas L, Wang Z, Yip C, Meng XY, Lin S, Zhang F, Zhang Z, Chan DW, Weinberger SR (2005) Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 115:783-789
133. Shi L, Zhang J, Wu P, Feng K, Li J, Xie Z, Xue P, Cai T, Cui Z, Chen X, Hou J, Zhang J, Yang F (2009) Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia. Proteome Sci 7:7
134. Sreseli RT, Binder H, Kuhn M, Digel W, Veelken H, Sienel W, Passlick B, Schumacher M, Martens UM, Zimmermann S (2010) Identification of a 17-protein signature in the serum of lung cancer patients. Oncol Rep 24:263-270
135. Ward DG, Wei W, Buckels J, Taha AM, Hegab B, Tariciotti L, Salih R, Qi YQ, Martin A, Johnson PJ (2010) Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen. Eur J Gastroenterol Hepatol 22:1358-1363
136. Ziegler ME, Chen T, LeBlanc JF, Wei X, Gjertson DW, Li KC, Khalighi MA, Lassman CR, Veale JL, Gritsch HA, Reed EF (2011) Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection. Transplantation 92:388-395
137. Johnston O, Cassidy H, O'Connell S, O'Riordan A, Gallagher W, Maguire PB, Wynne K, Cagney G, Ryan MP, Conlon PJ, Mcmorrow T (2011) Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods. Proteomics Clin Appl 5:422-431
138. Zhang Q, Wang J, Dong R, Yang S, Zheng S (2011) Identification of novel serum biomarkers in child nephroblastoma using proteomics technology. Mol Biol Rep 38:631-638
139. Flood-Nichols SK, Tinnemore D, Wingerd MA, Abu-Alya AI, Napolitano PG, Stallings JD, Ippolito DL (2012) Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: A targeted proteomics approach. Mol Cell Proteomics. doi:10.1074/mcp.M112.018192
140. Poon TC, Johnson PJ (2001) Proteome analysis and its impact on the discovery of serological tumor markers. Clin Chim Acta 313:231-239
141. Ang IL, Poon TC, Lai PB, Chan AT, Ngai SM, Hui AY, Johnson PJ, Sung JJ (2006) Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: A glycoproteomic approach. J Proteome Res 5:2691-2700
142. Jain MR, Bian S, Liu T, Hu J, Elkabes S, Li H (2009) Altered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cord. Proteome Sci 7:25
143. Toyama A, Nakagawa H, Matsuda K, Ishikawa N, Kohno N, Daigo Y, Sato TA, Nakamura Y, Ueda K (2011) Deglycosylation and label-free quantitative LC-MALDI MS applied to efficient serum biomarker discovery of lung cancer. Proteome Sci 9:18
144. Li Y, Zhou K, Zhang Z, Sun L, Yang J, Zhang M, Ji B, Tang K, Wei Z, He G, Gao L, Yang L, Wang P, Yang P, Feng G, He L, Wan C (2012) Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: Evidence for the immune hypothesis of schizophrenia. Mol Biosyst 2012:2664-2671
145. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577
146. Sorace JM, Zhan M (2003) A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics 4:24
147. Baggerly KA, Morris JS, Coombes KR (2004) Reproducibility of SELDI-TOF protein patterns in serum: Comparing datasets from different experiments. Bioinformatics 20: 777-785
148. Baggerly KA, Morris JS, Edmonson SR, Coombes KR (2005) Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst 97: 307-309
149. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62:3609-3614
150. McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, Chan DW, Diaz J, Izbicka E, Kagan J, Malehorn DE, Malik G, Oelschlager D, Partin A, Randolph T, Rosenzweig N, Srivastava S, Srivastava S, Thompson IM, Thornquist M, Troyer D, Yasui Y, Zhang Z, Zhu L, Semmes OJ (2008) Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: Sources of sample bias. Clin Chem 54:44-52
151. Yip TT, Chan JW, Cho WC, Yip TT, Wang Z, Kwan TL, Law SC, Tsang DN, Chan JK, Lee KC, Cheng WW, Ma VW, Yip C, Lim CK, Ngan RK, Au JS, Chan A, Lim WW, Ciphergen SARS Proteomics Study Group (2005) Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem 51:47-55
152. Kang X, Xu Y, Wu X, Liang Y, Wang C, Guo J, Wang Y, Chen M, Wu D, Wang Y, Bi S, Qiu Y, Lu P, Cheng J, Xiao B, Hu L, Gao X, Liu J, Wang Y, Song Y, Zhang L, Suo F, Chen T, Huang Z, Zhao Y, Lu H, Pan C, Tang H (2005) Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem 51:56-64
153. Pang RT, Poon TC, Chan KC, Lee NL, Chiu RW, Tong YK, Chim SS, Sung JJ, Lo YM (2006) Serum amyloid A is not useful in the diagnosis of severe acute respiratory syndrome. Clin Chem 52:1202-1204
154. McKernan M, McMillan DC, Anderson JR, Angerson WJ, Stuart RC (2008) The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 98:888-893
155. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576
156. Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R, Cannabis and Respiratory Disease Research Group (2008) Cannabis use and risk of lung cancer: A case-control study. Eur Respir J 31:280-286
157. Jorde R, Saleh F, Figenschau Y, Kamycheva E, Haug E, Sundsfjord J (2005) Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromsø study. Eur J Endocrinol 152:39-45
158. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, Van Haaften-Day C, Hacker NF, de Bruijn HW, van der Zee AG, Jacobs IJ, Fung ET, Chan DW (2004) Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64:5882-5890
159. Zhang Z, Chan DW (2005) Cancer proteomics: In pursuit of "true" biomarker discovery. Cancer Epidemiol Biomarkers Prev 14:2283-2286
160. Rai AJ, Zhang Z, Rosenzweig J, IeM S, Pham T, Fung ET, Sokoll LJ, Chan DW (2002) Proteomic approaches to tumor marker discovery. Arch Pathol Lab Med 126:1518-1526
161. Zhang Z, Chan DW (2010) The road from discovery to clinical diagnostics: Lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. Cancer Epidemiol Biomarkers Prev 19:2995-2999